These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 1901563)

  • 41. Safety of the nonselective NSAID nabumetone : focus on gastrointestinal tolerability.
    Bannwarth B
    Drug Saf; 2008; 31(6):485-503. PubMed ID: 18484783
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative gastrointestinal blood loss associated with placebo, aspirin, and nabumetone as assessed by radiochromium (51Cr).
    Lussier A; Davis A; Lussier Y; Lebel E
    J Clin Pharmacol; 1989 Mar; 29(3):225-9. PubMed ID: 2786009
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effects of smoking and indomethacin on small intestinal permeability.
    Suenaert P; Bulteel V; Den Hond E; Hiele M; Peeters M; Monsuur F; Ghoos Y; Rutgeerts P
    Aliment Pharmacol Ther; 2000 Jun; 14(6):819-22. PubMed ID: 10848667
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential trafficking of saccharidic probes following aspirin in clinical tests of intestinal permeability in young healthy women.
    Sequeira IR; Lentle RG; Kruger MC; Hurst RD
    Clin Exp Pharmacol Physiol; 2014 Feb; 41(2):107-17. PubMed ID: 24033480
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mitochondrial damage: a possible mechanism of the "topical" phase of NSAID induced injury to the rat intestine.
    Somasundaram S; Rafi S; Hayllar J; Sigthorsson G; Jacob M; Price AB; Macpherson A; Mahmod T; Scott D; Wrigglesworth JM; Bjarnason I
    Gut; 1997 Sep; 41(3):344-53. PubMed ID: 9378390
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of non-steroidal anti-inflammatory drugs on neutrophil chemotaxis--an in vitro and in vivo study.
    Ip M; Lomas DA; Shaw J; Burnett D; Stockley RA
    Br J Rheumatol; 1990 Oct; 29(5):363-7. PubMed ID: 2224405
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Properties and features of nabumetone].
    Davies NM; McLachlan AJ
    Drugs; 2000; 59 Spec No 1():25-33. PubMed ID: 10841070
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vivo influence of nicotine on human basal and NSAID-induced gut barrier function.
    Suenaert P; Bulteel V; Den Hond E; Geypens B; Monsuur F; Luypaerts A; Ghoos Y; Rutgeerts P
    Scand J Gastroenterol; 2003 Apr; 38(4):399-408. PubMed ID: 12739712
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regulation of polyethylene glycol 400 intestinal permeability by endogenous and exogenous prostanoids. Influence of non-steroidal anti-inflammatory drugs.
    Krugliak P; Hollander D; Le K; Ma T; Dadufalza VD; Katz KD
    Gut; 1990 Apr; 31(4):417-21. PubMed ID: 2338266
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preclinical overview of nabumetone. Pharmacology, bioavailability, metabolism, and toxicology.
    Mangan FR; Flack JD; Jackson D
    Am J Med; 1987 Oct; 83(4B):6-10. PubMed ID: 3688000
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nabumetone (BRL 14777, 4-[6-methoxy-2-naphthyl]-butan-2-one): a new anti-inflammatory agent.
    Boyle EA; Freeman PC; Mangan FR; Thomson MJ
    J Pharm Pharmacol; 1982 Sep; 34(9):562-9. PubMed ID: 6127380
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased intestinal permeability in patients with rheumatoid arthritis: a side-effect of oral nonsteroidal anti-inflammatory drug therapy?
    Jenkins RT; Rooney PJ; Jones DB; Bienenstock J; Goodacre RL
    Br J Rheumatol; 1987 Apr; 26(2):103-7. PubMed ID: 3103807
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nabumetone. A reappraisal of its pharmacology and therapeutic use in rheumatic diseases.
    Friedel HA; Langtry HD; Buckley MM
    Drugs; 1993 Jan; 45(1):131-56. PubMed ID: 7680981
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Experimental non-steroidal anti-inflammatory drug-induced enteropathy in the rat: similarities to inflammatory bowel disease and effect of thromboxane synthetase inhibitors.
    Banerjee AK; Peters TJ
    Gut; 1990 Dec; 31(12):1358-64. PubMed ID: 1979954
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Different effects of indomethacin and nabumetone on prostaglandin-mediated gastric responses to central vagal activation in rats.
    Cardin S; Soll AH; Taché Y
    J Pharmacol Exp Ther; 1995 Nov; 275(2):667-73. PubMed ID: 7473153
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intestinal permeability assessed by 51Cr-EDTA in rats with CCl4 - induced cirrhosis.
    Ramos AR; Matte U; Goldani HA; Oliveira OL; Vieira SM; Silveira TR
    Arq Gastroenterol; 2010; 47(2):188-92. PubMed ID: 20721466
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use of an orally administered combined sugar solution to evaluate intestinal absorption and permeability in cats.
    Johnston KL; Ballèvre OP; Batt RM
    Am J Vet Res; 2001 Jan; 62(1):111-8. PubMed ID: 11197547
    [TBL] [Abstract][Full Text] [Related]  

  • 58. COX-2 inhibition with rofecoxib does not increase intestinal permeability in healthy subjects: a double blind crossover study comparing rofecoxib with placebo and indomethacin.
    Sigthorsson G; Crane R; Simon T; Hoover M; Quan H; Bolognese J; Bjarnason I
    Gut; 2000 Oct; 47(4):527-32. PubMed ID: 10986213
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lactulose, 51Cr-labelled ethylenediaminetetra-acetate, L-rhamnose and polyethyleneglycol 400 [corrected] as probe markers for assessment in vivo of human intestinal permeability.
    Maxton DG; Bjarnason I; Reynolds AP; Catt SD; Peters TJ; Menzies IS
    Clin Sci (Lond); 1986 Jul; 71(1):71-80. PubMed ID: 3086024
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nabumetone. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in rheumatic diseases.
    Friedel HA; Todd PA
    Drugs; 1988 May; 35(5):504-24. PubMed ID: 3293969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.